256737 FDA's action plan to combat to public health threat of tobacco use

Monday, October 29, 2012 : 8:30 AM - 8:45 AM

Ashley Ross, BA, MPH , Center for Tobacco Products, U.S. Food and Drug Administration, US Food and Drug Administration (FDA), Rockville, MD
This session will help the public health community understand the authority granted to the Food and Drug Administration (FDA) through the 2009 Family Smoking Prevention and Tobacco Control Act to regulate the manufacture, marketing and distribution of tobacco products; how this new authority varies from the traditional tobacco control community; the progress made to date by the FDA's Center for Tobacco Products in carrying out this authority, including its regulatory framework; and how best to engage with and complement the FDA in these efforts.

Learning Areas:
Advocacy for health and health education
Chronic disease management and prevention
Communication and informatics
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
1) Describe the authority given to the FDA through the Tobacco Control Act. 2) Identify progress made by the FDA’s Center for Tobacco Products since the inception of the Act. 3) Evaluate the Center’s Regulatory Framework and discuss corresponding next steps, and how best to engage with the Center and support the Act.

Keywords: Tobacco Legislation, Local Public Health Agencies

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As an MPH, Policy Analyst, I work in the Office of Policy at the FDA's Center for Tobacco Products and am responsible for educating stakeholders about the Tobacco Control Act and the ways in which the public health community and the FDA can support each other's tobacco control efforts.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3003.0: FDA: A New Role in Tobacco Regulation